Table TDI-11. Characteristics of new clients treated for drug problems: demographics and main drug at treatment in 2002 or most recent year available. Part (i) Demographics and injecting status
| Country | Year | No. of clients | Mean age | % Age <25 | % Age 35+ | % Male | % Injecting main drug | ||
| Belgium | (1) | 1999 | 4826 | 24.5 | 63 | 13 | 76 | 8 | |
| Czech Republic | (2) | 2002 | 4719 | 21.8 | 75.8 | 4.1 | 67 | 55.3 | |
| Denmark | 2002 | 1062 | 28.3 | 44 | 25 | 78 | 10 | ||
| Germany | (4) | 2002 | 9574 | 25.9 | 65 | 11 | 81 | na | |
| Greece | 2002 | 1787 | 27.7 | 47.8 | 20.8 | 83.9 | 47.7 | ||
| Spain | 2002 | 17228 | 28.3 | 37 | 20 | 85 | 5.9 | ||
| France | (5) | 1999 | 5785 | 29 | 31 | 42 | 80 | na | |
| Ireland | (6) | 2000 | 1981 | 23.2 | 68.4 | 7 | 77 | 22.8 | |
| Italy | (7) | 2002 | 32892 | 29.3 | 32 | 24.7 | 87 | na | |
| Latvia | (8) | 2002 | 220 | 23.8 | 66.4 | 7.6 | 73.2 | na | |
| Lithuania | 2002 | 471 | 25.6 | 69 | 7 | 81.3 | na | ||
| Luxembourg | (10) | 2002 | 24 | 27.3 | na | na | na | na | |
| Hungary | 2002 | 4717 | na | 46 | 21 | 62 | na | ||
| Netherlands | (12) | 2002 | 4847 | 30.5 | 35 | 29 | 79 | 3 | |
| Austria | (13) | 2002 | 689 | 26.5 | 50.7 | 17.1 | 74 | na | |
| Portugal | (14) | 2002 | 5405 | 31.8 | 19.2 | 30.1 | 83.9 | na | |
| Slovenia | 2002 | 528 | 22.4 | 75.3 | 4 | 73.9 | 48.7 | ||
| Slovakia | 2002 | 843 | 24.6 | 64.4 | 9.1 | 78.7 | 47.8 | ||
| Finland | 2002 | 986 | 24.8 | 73.4 | 7 | 72 | 38.7 | ||
| Sweden | (15) | 2002 | 545 | 31 | 42 | 32 | 63 | 7 | |
| United Kingdom | (16) | 2002 | na | na | na | na | na | na | |
| Notes: | |||||||||
| Data were not available for: Estonia, Cyprus, Malta, Poland and Norway. | |||||||||
| Belgium | (1) | Data refer only to outpatient treatment centres. Last data available refer to 1999. | |||||||
| Czech Republic | (2) | Data refer to all treatment centres. | |||||||
| Germany | (4) | Data only refer to outpatient treatment centres; information about injecting use is not available. | |||||||
| France | (5) | The last available data on treatment demand are reported, referring to the annual census on clients in treatment carried out in November 1999. | |||||||
| Ireland | (6) | Last data available refer to 2000. | |||||||
| Italy | (7) | Data only refer to outpatient treatment centres; information about injecting opiate use refers only to heroin, for cocaine only to cocaine CIH. | |||||||
| Latvia | (8) | Data refer only to outpatient treatment centres. | |||||||
| Luxembourg | (10) | Data on first treatment only partially available. | |||||||
| Netherlands | (12) | Data refer only to outpatient treatment centres. | |||||||
| Austria | (13) | Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%. | |||||||
| Portugal | (14) | Coverage is limited and variable, with no control on double counting of clients. | |||||||
| Sweden | (15) | Data refer only to out-patient treatment centres. | |||||||
| United Kingdom | (16) | Data relate to the period from 1 April 2001 to 31 March 2002 for Scotland and Northern Ireland; for England and Wales six months data ending 30 September 2000 plus six months data ending 31 March 2001. | |||||||
| Associated graphic: | |||||||||
| Trends in current injecting drug use amongst heroin users in treatment [Figure9OL]. | |||||||||
| Sources: 2003 Reitox national reports, Standard table 3, see [Table TDI-10 Part (iii)] for details on sources. | |||||||||
